Renée JG Arnold PharmD, RPh

Course Description

This module is an introduction to the role of cost-consequence (CC)/cost-minimization analysis(CMA) in medical decision making from multiple perspectives. It will describe situations in which CCA/CMA is the acceptable method of pharmacoeconomic (PE) analysis, the components included, computational methods, the concept of efficacy vs. effectiveness and establishing equivalent outcomes.

Learning Objectives

By the end of the Cost-Minimization/Cost-Consequence (CMA/CCA) module, you will be able to:

  • State the role of cost-consequence (CC)/cost-minimization analysis (CMA) in medical decision making.
  • Contrast the price of a drug product and the cost of drug therapy.
  • Define the components of CC/CMA.
  • Understand the computations involved in CC/CMA.
  • Understand the concerns in attribution of cost components to a particular treatment arm.
  • Summarize the resources used in a therapy or service and assign monetary values to those resources.
  • Analyze the value for money from health technologies.
  • Summarize how CC/CMA are used in health policy decisions regarding government approval of and reimbursement for therapies.
  • Use and apply sensitivity analyses and discounting techniques in CC/CMA.
  • Explain how point of view and perspective affect CC/CMA.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now